Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells

<div>Differentiation of MSCs via chemical compounds. AD-MSCs [<a href="/journals/sci/2016/3764681/#B99">49</a>–<a href="/journals/sci/2016/3764681/#B156">54</a>] and BM-MSCs [<a href="/journals/sci/2016/3764681/#B122">51</a>, <a href="/journals/sci/2016/3764681/#B157">55</a>–<a href="/journals/sci/2016/3764681/#B159">57</a>].</div>

Stem Cells International

fig3

Figure 3

Figure 3: Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells 